JW THERAP-B News

JW THERAP-B: GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULES 14A.52 AND 14A.53 OF THE LISTING RULES UNDER THE LICENSE AND STRATEGIC ALLIANCE AGREEMENT

Apr 26 07:06

JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 18, 2024

Apr 26 06:58

JW THERAP-B: NOTICE OF ANNUAL GENERAL MEETING

Apr 26 06:53

JW THERAP-B: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARES OUT OF TREASURY AND REPURCHASE SHARES AND RE-ELECTION OF DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

Apr 26 06:48

JW THERAP-B: PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION

Apr 26 06:41

JW THERAP-B: 2023 Environmental, Social and Governance Report

Apr 26 06:35

JW THERAP-B: 2023 ANNUAL REPORT

Apr 26 06:21

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 16:32

JW THERAP-B: Next Day Disclosure Return

Apr 2 19:36

JW THERAP-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING

Mar 20 16:34

JW THERAP-B: NOTICE OF BOARD MEETING

Mar 8 16:45

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 6 16:56

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 16:39

JW THERAP-B: Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jan 19 16:35

JW THERAP-B: Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jan 19 16:33

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NMPA ACCEPTANCE OF THE SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION FOR CARTEYVA IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

Jan 4 21:29

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 16:39

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC.

Jan 2 20:01

JW THERAP-B: RESIGNATION OF CHIEF FINANCIAL OFFICER

Dec 15, 2023 20:00

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 16:43